부산대학교 도서관

Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Xiong N; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Cheng SC; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Barry WT; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Penson RT; Department of Medical Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States of America.; Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Hoffman MA; Long Island Jewish Medical Center, New Hyde Park, NY, United States of America.; Horowitz N; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Obstetrics & Gynecology, Brigham & Women's Hospital, Boston, MA, United States of America.; Dizon DS; Brown University, Division of Women's Cancers, Lifespan Cancer Institute, Providence, RI, United States of America.; Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Wright AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Campos SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Krasner C; Department of Medical Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States of America.; Morrissey S; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Whalen C; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Quinn R; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: Ursula_Matulonis@dfci.harvard.edu.; Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: Joyce_Liu@dfci.harvard.edu.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Penson RT; Richard T. Penson MRCP, MD, Massachusetts General Hospital, Boston, MA; and Elizabeth S. Lowe ScM, MD, AstraZeneca Pharmaceuticals, Gaithersburg, MD.; Lowe ES; Richard T. Penson MRCP, MD, Massachusetts General Hospital, Boston, MA; and Elizabeth S. Lowe ScM, MD, AstraZeneca Pharmaceuticals, Gaithersburg, MD.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: panagiotis_konstantinopoulos@dfci.harvard.edu.; Cheng SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wahner Hendrickson AE; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.; Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.; Schumer ST; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Doyle LA; Department of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kohn EC; Department of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Duska LR; Department of Obstetrics and Gynecology, Cancer Center, University of Virginia, Charlottesville, VA, USA.; Crispens MA; Department of Obstetrics and Gynecology, Ingram Cancer Center, Vanderbilt University Nashville, TN, USA.; Olawaiye AB; Department of Obstetrics and Gynecology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.; Winer IS; Department of Obstetrics and Gynecology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Barroilhet LM; Department of Obstetrics and Gynecology, University of Wisconsin Hospital and Clinics, Madison, WI, USA.; Fu S; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX, USA.; McHale MT; Department of Obstetrics and Gynecology, Moores Cancer Center, University of California San Diego, San Diego, CA, USA.; Schilder RJ; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.; Färkkilä A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chowdhury D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Curtis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Quinn RS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bowes B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; D'Andrea AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Arend RC; University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.; Beer HM; University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.; Cohen YC; VBL Therapeutics, Modiin, Israel.; Berlin S; Dana Farber Cancer Institute, York, ME, USA.; Birrer MJ; University of Arkansas for Medical Sciences, Little Rock, AK, USA.; Campos SM; Dana Farber Cancer Institute, York, ME, USA.; Rachmilewitz Minei T; VBL Therapeutics, Modiin, Israel.; Harats D; VBL Therapeutics, Modiin, Israel.; Wall JA; University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.; Foxall ME; University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.; Penson RT; Massachusetts General Hospital, Boston, MA, USA. Electronic address: rpenson@partners.org.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Penson RT; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: penson.richard@mgh.harvard.edu.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Chase D; Arizona Oncology, Paradise Valley, California, USA dana.chase@usoncology.com.; Huang HQ; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA.; Monk BJ; Ob Gyn/Gyn Onc, Creighton University School of Medicine at St Josephs Hospital and Medical Center, Phoenix, Arizona, USA.; Ramondetta LM; Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Penson RT; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Gil K; Psychology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Landrum LM; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Leitao M; Memorial Sloan-Kettering Cancer Center, New York, New York, USA.; Oaknin A; Vall d' Hebron Institute of Oncology, University Hospital, Barcelona, Spain.; Huh WK; University of Alabama at Birmingham, Birmingham, Alabama, USA.; Pulaski HL; Gynecological Oncology, University of Cincinnati, Cincinnati, Ohio, USA.; Robison K; Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA.; Guntupalli SR; Gynecologic Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA.; Richardson D; UT Southwestern Medical, Dallas, Texas, USA.; Salani R; Ob/Gyn, Ohio State University, Columbus, Ohio, USA.; Sill MW; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA.; Wenzel LB; University of California Irvine School of Medicine, Irvine, California, USA.; Tewari KS; University of California Irvine School of Medicine, Orange, California, USA.

Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

O'Malley DM; The Ohio State University, Columbus, OH, United States. Electronic address: David.O'Malley@osumc.edu.; Matulonis UA; Dana Farber Cancer Institute, Boston, MA, United States. Electronic address: Ursula_Matulonis@dfci.harvard.edu.; Birrer MJ; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, United States. Electronic address: mbirrer@uab.edu.; Castro CM; Massachusetts General Hospital, Boston, MA, United States. Electronic address: Castro.Cesar@mgh.harvard.edu.; Gilbert L; McGill University Health Centre, Montreal, QC, Canada. Electronic address: lucy.gilbert@mcgill.ca.; Vergote I; Leuven Cancer Institute, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be.; Martin LP; University of Pennsylvania, Philadelphia, PA, United States. Electronic address: Lainie.Martin@uphs.upenn.edu.; Mantia-Smaldone GM; Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address: Gina.Mantia-Smaldone@fccc.edu.; Martin AG; Clinica Universidad de Navarra, Madrid, Spain. Electronic address: agonzalezma@unav.es.; Bratos R; MD Anderson Cancer Center Madrid, Madrid, Spain. Electronic address: rbratosl@hospiten.com.; Penson RT; Massachusetts General Hospital, Boston, MA, United States. Electronic address: Penson.Richard@mgh.harvard.edu.; Malek K; ImmunoGen, Inc., Waltham, MA, United States. Electronic address: karim.malek@immunogen.com.; Moore KN; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Sarah Cannon Research Institute, Nashville, TN, United States. Electronic address: Kathleen-Moore@ouhsc.edu.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Penson RT; Harvard Medical School and Massachusetts General Hospital, Boston, MA.; Valencia RV; Centro Medico Dalinde, Mexico City, Mexico.; Cibula D; First Faculty of Medicine, Charles University and General University, Prague, Czech Republic.; Colombo N; University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, Italy.; Leath CA 3rd; University of Alabama, Birmingham, AL.; Bidziński M; Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland.; Kim JW; Seoul National University Hospital, Seoul, South Korea.; Nam JH; Asan Medical Center, Seoul, South Korea.; Madry R; Medical University K. Marcinkowski and Clinical Hospital of the Transfiguration, Poznań, Poland.; Hernández C; Oaxaca Site Management Organization, Oaxaca de Juarez, Mexico.; Mora PAR; Instituto COI de Educação e Pesquisa, Rio de Janeiro, Brazil.; Ryu SY; Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.; Milenkova T; AstraZeneca, Cambridge, United Kingdom.; Lowe ES; AstraZeneca, Gaithersburg, MD.; Barker L; AstraZeneca, Cambridge, United Kingdom.; Scambia G; Università Cattolica del Sacro Cuore-Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Vergote I; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: Ignace.vergote@uzleuven.be.; Powell MA; Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA.; Teneriello MG; US Oncology Research, The Woodlands, TX, USA.; Miller DS; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Garcia AA; Louisiana State University, New Orleans, LA, USA.; Mikheeva ON; State Healthcare Institution Leningrad Regional Oncology Center, St Petersburg, Russia.; Bidzinski M; Maria Sklodowska-Curie Memorial Institute, Oncology Center, Warsaw, Poland.; Cebotaru CL; Department of Radiotherapy I-Medical Oncology, Prof Dr Ion Chircuta Institute of Oncology, Cluj Napoca, Romania.; Dutcus CE; Eisai Inc, Woodcliff Lake, NJ, USA.; Ren M; Eisai Inc, Woodcliff Lake, NJ, USA.; Kadowaki T; Eisai Co., Ltd., Tsukuba, Ibaraki, Japan.; Funahashi Y; Eisai Co., Ltd., Tsukuba, Ibaraki, Japan.; Penson RT; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Nitecki R; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA rnitecki@mdanderson.org.; Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Bercow AS; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Gockley AA; Gynecologic Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Lee H; Department of Medicine, MGH Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Penson RT; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Growdon WB; Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE